Consolidated Balance Sheets - USD ($) $ in Millions		Mar. 31, 2023		Dec. 31, 2022
Investments:
Fixed maturities available-for-sale, at fair value (amortized cost of $67,353 and $68,087) (allowance for credit losses of $18 and $24)		$ 59,726		$ 58,947
Mortgage loans on real estate (net of allowance for credit losses of $139 and $129)		16,952		16,464
Policy loans		3,556		3,563
Other equity investments		2,982	[1]	2,942
Trading securities, at fair value		292		283
Other invested assets		3,121		2,835
Total investments		86,629		85,034
Cash and cash equivalents		1,756		797
Deferred policy acquisition costs		4,817		4,814
Amounts due from reinsurers (allowance for credit losses of $0 and $10)		7,136	[2]	7,131
Loans to affiliates		1,900		1,900
Current and deferred income taxes		1,857		1,376
Purchased market risk benefits		10,743		10,490
Other assets		3,491		3,917
Assets for market risk benefits		612		478
Separate Accounts assets		115,885		111,479
Total Assets		234,826		227,416
LIABILITIES
Policyholders’ account balances		81,497		79,742
Liability for market risk benefits		15,047		15,751
Future policy benefits and other policyholders' liabilities		16,033		15,935
Broker-dealer related payables		321		95
Amounts due to reinsurers		184		282
Other liabilities		4,612		5,185
Separate Accounts liabilities		115,885		111,479
Total Liabilities		233,579		228,469
Redeemable noncontrolling interest		19	[3]	21
Commitments and contingent liabilities	[4]
Equity attributable to Equitable Financial:
Common stock, $1.25 par value; 2,000,000 shares authorized, issued and outstanding		2		2
Additional paid-in capital		8,524		8,536
Accumulated deficit		(1,776)		(1,757)
Accumulated other comprehensive income (loss)		(5,522)		(7,855)
Total equity attributable to Equitable Financial		1,228		(1,074)
Noncontrolling interest		0		0
Total Equity		1,228		(1,074)
Total Liabilities, Redeemable Noncontrolling Interest and Equity		$ 234,826		$ 227,416

[1] See Note 2 of the Notes to these Consolidated Financial Statements for details of balances with VIEs.

[2] Represents the fair value of the ceded reserves to Venerable. See Note 1 of the Notes to the Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 for details of the Venerable Transaction and Note 7 of the Notes to these Consolidated Financial Statements.(4)See Note 15 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.Prior period amounts have been adjusted for the implementation of ASU 2018-12: Targeted Improvements to the Accounting for Long-Duration Contracts.

[3] See Note 14 of the Notes to these Consolidated Financial Statements for details of redeemable noncontrolling interest.

[4] See Note 15 of the Notes to these Consolidated Financial Statements for details of commitments and contingent liabilities.Prior period amounts have been adjusted for the implementation of ASU 2018-12: Targeted Improvements to the Accounting for Long-Duration Contracts.